Literature DB >> 23265411

Gene therapy for the inner ear.

Hideto Fukui1, Yehoash Raphael.   

Abstract

Animal studies on inner ear development, repair and regeneration provide understanding of molecular pathways that can be harnessed for treating inner ear disease. Use of transgenic mouse technology, in particular, has contributed knowledge of genes that regulate development of hair cells and innervation, and of molecular players that can induce regeneration, but this technology is not applicable for human treatment, for practical and ethical reasons. Therefore other means for influencing gene expression in the inner ear are needed. We describe several gene vectors useful for inner ear gene therapy and the practical aspects of introducing these vectors into the ear. We then review the progress toward using gene transfer for therapies in both auditory and balance systems, and discuss the technological milestones needed to advance to clinical application of these methods.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23265411      PMCID: PMC3594056          DOI: 10.1016/j.heares.2012.11.017

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  87 in total

Review 1.  Hair cell fate decisions in cochlear development and regeneration.

Authors:  Douglas A Cotanche; Christina L Kaiser
Journal:  Hear Res       Date:  2010-05-05       Impact factor: 3.208

2.  Vestibular hair cell regeneration and restoration of balance function induced by math1 gene transfer.

Authors:  Hinrich Staecker; Mark Praetorius; Kim Baker; Douglas E Brough
Journal:  Otol Neurotol       Date:  2007-02       Impact factor: 2.311

3.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.

Authors:  A Fire; S Xu; M K Montgomery; S A Kostas; S E Driver; C C Mello
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

4.  Hair cell protection from aminoglycoside ototoxicity by adenovirus-mediated overexpression of glial cell line-derived neurotrophic factor.

Authors:  M Yagi; E Magal; Z Sheng; K A Ang; Y Raphael
Journal:  Hum Gene Ther       Date:  1999-03-20       Impact factor: 5.695

5.  Ultrastructural evidence for hair cell regeneration in the mammalian inner ear.

Authors:  A Forge; L Li; J T Corwin; G Nevill
Journal:  Science       Date:  1993-03-12       Impact factor: 47.728

Review 6.  Development of gene therapy for inner ear disease: Using bilateral vestibular hypofunction as a vehicle for translational research.

Authors:  Hinrich Staecker; Mark Praetorius; Douglas E Brough
Journal:  Hear Res       Date:  2011-01-18       Impact factor: 3.208

7.  In vivo delivery of recombinant viruses to the fetal murine cochlea: transduction characteristics and long-term effects on auditory function.

Authors:  Jeffrey C Bedrosian; Michael Anne Gratton; John V Brigande; Waixing Tang; Jessica Landau; Jean Bennett
Journal:  Mol Ther       Date:  2006-06-09       Impact factor: 11.454

8.  Drug delivery to the cochlea using PLGA nanoparticles.

Authors:  Tetsuya Tamura; Tomoko Kita; Takayuki Nakagawa; Tsuyoshi Endo; Tae-Soo Kim; Tsutomu Ishihara; Yutaka Mizushima; Megumu Higaki; Juichi Ito
Journal:  Laryngoscope       Date:  2005-11       Impact factor: 3.325

9.  Noninvasive in vivo delivery of transgene via adeno-associated virus into supporting cells of the neonatal mouse cochlea.

Authors:  Takashi Iizuka; Sho Kanzaki; Hideki Mochizuki; Ayako Inoshita; Yuya Narui; Masayuki Furukawa; Takeshi Kusunoki; Makoto Saji; Kaoru Ogawa; Katsuhisa Ikeda
Journal:  Hum Gene Ther       Date:  2008-04       Impact factor: 5.695

10.  Gene transfer using bovine adeno-associated virus in the guinea pig cochlea.

Authors:  S B Shibata; G Di Pasquale; S R Cortez; J A Chiorini; Y Raphael
Journal:  Gene Ther       Date:  2009-05-21       Impact factor: 5.250

View more
  22 in total

Review 1.  [Gene therapy and stem cells for the inner ear: a review].

Authors:  H A Breinbauer; M Praetorius
Journal:  HNO       Date:  2014-02       Impact factor: 1.284

Review 2.  Strategies for a regenerative therapy of hearing loss.

Authors:  M Diensthuber; T Stöver
Journal:  HNO       Date:  2018-01       Impact factor: 1.284

3.  Delivery of Adeno-Associated Virus Vectors in Adult Mammalian Inner-Ear Cell Subtypes Without Auditory Dysfunction.

Authors:  Yong Tao; Mingqian Huang; Yilai Shu; Adam Ruprecht; Hongyang Wang; Yong Tang; Luk H Vandenberghe; Qiuju Wang; Guangping Gao; Wei-Jia Kong; Zheng-Yi Chen
Journal:  Hum Gene Ther       Date:  2018-01-22       Impact factor: 5.695

Review 4.  Potential treatments for genetic hearing loss in humans: current conundrums.

Authors:  R Minoda; T Miwa; M Ise; H Takeda
Journal:  Gene Ther       Date:  2015-03-17       Impact factor: 5.250

Review 5.  Emerging Gene Therapies for Genetic Hearing Loss.

Authors:  Hena Ahmed; Olga Shubina-Oleinik; Jeffrey R Holt
Journal:  J Assoc Res Otolaryngol       Date:  2017-08-16

Review 6.  Research progress on flat epithelium of the inner ear.

Authors:  L He; J-Y Guo; K Liu; G-P Wang; S-S Gong
Journal:  Physiol Res       Date:  2020-09-09       Impact factor: 1.881

7.  Nonviral Reprogramming of Human Wharton's Jelly Cells Reveals Differences Between ATOH1 Homologues.

Authors:  Adam J Mellott; Keerthana Devarajan; Heather E Shinogle; David S Moore; Zsolt Talata; Jennifer S Laurence; M Laird Forrest; Sumihare Noji; Eiji Tanaka; Hinrich Staecker; Michael S Detamore
Journal:  Tissue Eng Part A       Date:  2015-04-13       Impact factor: 3.845

Review 8.  Sound strategies for hearing restoration.

Authors:  Gwenaëlle S G Géléoc; Jeffrey R Holt
Journal:  Science       Date:  2014-05-09       Impact factor: 47.728

9.  Assessment of nutrient supplement to reduce gentamicin-induced ototoxicity.

Authors:  C G Le Prell; C Ojano-Dirain; E W Rudnick; M A Nelson; S J DeRemer; D M Prieskorn; J M Miller
Journal:  J Assoc Res Otolaryngol       Date:  2014-03-04

Review 10.  [Strategies for a regenerative therapy of hearing loss. German version].

Authors:  M Diensthuber; T Stöver
Journal:  HNO       Date:  2018-03       Impact factor: 1.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.